#SFHS2608374VNotice Regarding Pharmaceutical Specialty Prices
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
This notice sets the prices for specific pharmaceutical products, specifically the injectable solutions YESINTEK 45 mg and 90 mg by Biocon Biologics France. Businesses in France need to adjust their pricing and stock strategies accordingly as the new rates take effect shortly after official publication.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Sets new prices for YESINTEK 45 mg and 90 mg injectable solutions.
- Prices effective shortly after official publication.
- Impacts pharmaceutical pricing strategies in France.
Obligations
What this law requires
Update pricing for YESINTEK 45 mg (CIP 34009 303 335 1 8) to PFHT €1,020.04 and PPTTC €1,128.53
Update pricing for YESINTEK 90 mg (CIP 34009 303 335 2 5) to PFHT €1,020.04 and PPTTC €1,128.53
Implement the new prices effective from the fourth day following publication in the Journal officiel de la République française
Adjust inventory and stock strategies to reflect the newly established pharmaceutical specialty prices